跳至主要内容
临床试验/NCT01730391
NCT01730391已完成不适用

Neisseria Meningitidis Burden of Disease

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 521 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
521
试验地点
1
主要终点
Serogroup of N. meningitis positive samples

研究概览

简要总结

This study aims to provide an estimate of the proportion of suspected cases of bacterial meningitis that are due to N. meningitidis and the serogroup responsible in The Philippines and Vietnam.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Subjects who the investigator believes can and will comply with the requirements of the protocol or subjects who the investigator believes that parent(s)/Legally Acceptable Representative(s) [LAR(s)] can and will comply with the requirements of the protocol.
  • Written informed consent obtained from the subject/from the parent(s)/LAR of the subject.
  • A male or female subject who visits the hospital with suspected bacterial meningitis.
  • CSF sample taken as part of routine practice.

排除标准

  • Child in care.

结局指标

主要结局

Serogroup of N. meningitis positive samples

时间窗: At enrollment (Day 0)

Prevalence of N. meningitis in CSF samples

时间窗: At enrollment (Day 0)

次要结局

  • Prevalence of Haemophilus influenzae and Streptococcus pneumoniae in CSF samples as causes of bacterial meningitis(At enrollment (Day 0))
  • Serotype of Streptococcus pneumoniae positive samples(At enrollment (Day 0))
  • Further characterization of N. meningitidis using Multi Locus Sequence Typing(At enrollment (Day 0))
  • Further classification of Haemophilus influenzae positive samples into Type B and non-B Types(At enrollment (Day 0))
  • Total number of subjects with suspected bacterial meningitis (according to diagnostic criteria used by each participating hospital to identify this condition)(At enrollment (Day 0))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Neisseria Meningitidis Burden of Disease Study | 临床试验